MSD has only just completed its $10 billion takeover of Verona Pharma, but is still on the hunt for more bolt-on acquisitions to flesh out its pipeline, according to chief executive Rob Davis. On the ...
MSD has announced a takeover deal for Cidara Therapeutics, an infectious disease specialist currently focused on developing a preventive antibody-based therapy for influenza. The agreement – first ...
Mikeie Reiland is a staff writer for Education at Forbes Advisor. Before coming to Forbes Advisor, he wrote magazine journalism for publications like the Oxford American, Bitter Southerner, and Gravy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback